EGFR and colorectal carcinoma: Spearman's analysis revealed significant positive correlations between NSUN2 and CUL4B (R = .672; p < .001), EGFR (R = .477; p < .001) and HER2 (R = .503; p < .001) in CRC patients (Figure 7E).